The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy
Abstract
It is uncertain what is the most appropriate medical therapy for patients with severe Graves' ophthalmopathy. Therefore, we carried out a single-blind, randomized clinical trial to compare the efficacy of prednisone with that of cyclosporine in 36 patients who had been euthyroid for at least two months. The two groups, each consisting of 18 patients, were similar in age, sex, and the duration and severity of ophthalmopathy. The initial dose of cyclosporine was 7.5 mg per kilogram of body weight per day, and that of prednisone was 60 mg per day, which was subsequently tapered to 20 mg per day. During the 12-week treatment period, 11 prednisone-treated and 4 cyclosporine-treated patients responded to therapy (61 percent vs. 22 percent; P = 0.018); response was manifested by decreases in eye-muscle enlargement and proptosis and improved visual acuity and total and subjective eye scores. There were no differences at base line between the patients who later responded and those who did not. Prednisone was tolerated less well than cyclosporine. After 12 weeks, patients who did not respond were treated for another 12 weeks with a combination of cyclosporine and a low dose of prednisone. Among the 9 patients who initially received prednisone, the addition of cyclosporine resulted in improvement in 5 (56 percent); among the 13 patients who received cyclosporine initially, 8 (62 percent) improved after the addition of prednisone. Combination therapy was better tolerated than prednisone treatment alone. We conclude that single-drug therapy with prednisone is more effective than cyclosporine in patients with severe Graves' ophthalmopathy. The combination can be effective in patients who do not respond to either drug alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mourits, M. P., Koornneef, L., Wiersinga, W. M., Prummel, M. F., Berghout, A., & van der Gaag, R. (1989) · British Journal of Ophthalmology · doi:10.1136/bjo.73.8.639 · Cited by 721
Self-citationWerner, S. C. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-1-203 · Cited by 466
Bartalena, L., Marcocci, C., Chiovato, L., Laddaga, M., Lepri, G., Andreani, D., Cavallacci, G., Baschieri, L., & Pinchera, A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1139 · Cited by 272
Supervoltage Orbital Radiotherapy for Graves' Ophthalmopathy1
DONALDSON, S. S., BAGSHAW, M. A., & KRISS, J. P. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-2-276 · Cited by 251
Endocrine Ophthalmopathy: Current Ideas Concerning Etiology, Pathogenesis, and Treatment
JACOBSON, D. H., & GORMAN, C. A. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-2-200 · Cited by 211
KAHALY, G., SCHREZENMEIR, J., KRAUSE, U., SCHWEIKERT, B., MEUER, S., MULLER, W., DENNERAUM, R., & BEYER, J. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01016.x · Cited by 202
Choice of Therapy and Criteria for Assessing Treatment Outcome in Thyroid-associated Ophthalmopathy
Bahn, R. S., & Gorman, C. A. (1987) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30485-7 · Cited by 159
CYCLOSPORIN IMPROVES GRAVES' OPHTHALMOPATHY
Weetman, A. P., Ludgate, M. E., Mills, P. V., et al. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90514-7 · Cited by 114
Wiersinga, W. M., & CHOPRA, I. J. (1982) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(82)84024-x · Cited by 100
Self-citationRadiation Therapy for Thyroid Eye Diseases
Hurbli, T., Char, D. H., Harris, J., Weaver, K. A., Greenspan, F. S., & Sheline, G. (1985) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76027-1 · Cited by 91
Cited by
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy
Mourits, M. P., Prummel, M. F., Wiersinga, W. M., & Koornneef, L. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2331047.x · Cited by 1,001
Self-citationBartalena, L., Baldeschi, L., Boboridis, K., Eckstein, A., Kahaly, G. J., Marcocci, C., Perros, P., Salvi, M., & Wiersinga, W. M. (2016) · European Thyroid Journal · doi:10.1159/000443828 · Cited by 943
Self-citationManagement of Graves’ Ophthalmopathy: Reality and Perspectives*
Bartalena, L., Pinchera, A., & Marcocci, C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0393 · Cited by 677
Smoking and Risk of Graves' Disease
Prummel, M. F. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500040045034 · Cited by 503
Self-citationBartalena, L., Baldeschi, L., Dickinson, A. J., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M. P., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0315 · Cited by 406
Self-citation
Metadata
- Authors
- Prummel, M. F., Mourits, M. P., Berghout, A., Krenning, E. P., van der Gaag, R., Koornneef, L., & Wiersinga, W. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1989-11-16
- Volume
- 321
- Issue
- 20
- Pages
- 1353-1359
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2334870842
- Cited by
- 359
- References
- 14
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy. https://app.cochat.ai/papers/10.1056/nejm198911163212002
- The paper
- Prummel, M. F., Mourits, M. P., Berghout, A., Krenning, E. P., van der Gaag, R., Koornneef, L., & Wiersinga, W. M. (1989). Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy. New England Journal of Medicine. https://doi.org/10.1056/nejm198911163212002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.